Scalper1 News
Generic-drug giant Mylan (MYL) announced Monday that it’s buying $800 million in assets of an India-based women’s-health company. Mylan also bought into a lung-disease drug candidate. Mylan agreed to pay $750 million upfront plus up to $50 million in contingent payments for “certain female health care businesses” of Famy Care, with which Mylan has had a partnership since 2008. “This transaction especially complements Mylan’s pending acquisition of Scalper1 News
Scalper1 News